Simon Eggington

919 total citations
35 papers, 676 citations indexed

About

Simon Eggington is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Simon Eggington has authored 35 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 11 papers in Economics and Econometrics and 7 papers in Epidemiology. Recurrent topics in Simon Eggington's work include Health Systems, Economic Evaluations, Quality of Life (11 papers), Cardiac pacing and defibrillation studies (6 papers) and Pain Management and Treatment (5 papers). Simon Eggington is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (11 papers), Cardiac pacing and defibrillation studies (6 papers) and Pain Management and Treatment (5 papers). Simon Eggington collaborates with scholars based in Switzerland, United Kingdom and United States. Simon Eggington's co-authors include Paul Tappenden, J. Chilcott, Daniel Hind, Paul Sutcliffe, Julietta Patnick, Jonathan Karnon, Candy McCabe, Jeremy E. Oakley, Sue Ward and S Hummel and has published in prestigious journals such as Circulation, Gut and British Journal of Cancer.

In The Last Decade

Simon Eggington

31 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Eggington Switzerland 13 222 181 116 111 96 35 676
Sanjeev Balu United States 15 144 0.6× 136 0.8× 39 0.3× 175 1.6× 123 1.3× 48 988
Frédéric Pamoukdjian France 14 285 1.3× 70 0.4× 207 1.8× 132 1.2× 35 0.4× 42 917
Roberta Ciampichini Italy 12 182 0.8× 190 1.0× 102 0.9× 117 1.1× 20 0.2× 40 733
Jinn‐Ing Liou United States 11 418 1.9× 34 0.2× 178 1.5× 238 2.1× 126 1.3× 18 863
Sorrel Wolowacz United States 16 109 0.5× 254 1.4× 101 0.9× 248 2.2× 435 4.5× 50 1.1k
Trevor A. Jolly United States 14 460 2.1× 118 0.7× 252 2.2× 69 0.6× 34 0.4× 32 953
Geert Frederix Netherlands 16 78 0.4× 67 0.4× 128 1.1× 124 1.1× 323 3.4× 61 945
Raquel Aguiar‐Ibáñez United States 10 124 0.6× 66 0.4× 188 1.6× 248 2.2× 25 0.3× 45 515
William B. Feldman United States 14 71 0.3× 237 1.3× 80 0.7× 43 0.4× 19 0.2× 79 623

Countries citing papers authored by Simon Eggington

Since Specialization
Citations

This map shows the geographic impact of Simon Eggington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Eggington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Eggington more than expected).

Fields of papers citing papers by Simon Eggington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Eggington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Eggington. The network helps show where Simon Eggington may publish in the future.

Co-authorship network of co-authors of Simon Eggington

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Eggington. A scholar is included among the top collaborators of Simon Eggington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Eggington. Simon Eggington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nyholm, Dag, et al.. (2025). Therapies for Advanced Parkinson’s Disease in Sweden: A Cost-Effectiveness Analysis Using Real-World Data. Neurology and Therapy. 14(3). 801–812.
2.
Eggington, Simon, et al.. (2024). Optimizing Healthcare Expenditure for Spinal Cord Stimulation in Italy: The Value of Battery Longevity Improvement and a Direct-to-Implant Approach. Journal of health economics and outcomes research. 11(1). 149–156.
3.
Gulve, Ashish, et al.. (2024). Differential Target Multiplexed Spinal Cord Stimulation: A UK Cost-Effectiveness Analysis. Neuromodulation Technology at the Neural Interface. 27(5). 908–915. 1 indexed citations
4.
Eggington, Simon, et al.. (2024). Optimizing Healthcare Expenditure for Spinal Cord Stimulation in Italy: The Value of Battery Longevity Improvement and a Direct-to-Implant Approach. Journal of health economics and outcomes research. 149–156. 1 indexed citations
5.
Eggington, Simon, et al.. (2024). Are Medical Device Characteristics Included in HTA Methods Guidelines and Reports? A Brief Review. Applied Health Economics and Health Policy. 22(5). 653–664. 2 indexed citations
6.
Cangelosi, Michael J., et al.. (2023). Evolving Use of Health Technology Assessment in Medical Device Procurement—Global Systematic Review: An ISPOR Special Interest Group Report. Value in Health. 26(11). 1581–1589. 4 indexed citations
7.
Witte, Klaus K., Georgios Tsivgoulis, Matthew R. Reynolds, et al.. (2021). Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation. BMC Cardiovascular Disorders. 21(1). 160–160. 7 indexed citations
8.
Hopkins, Thomas J., et al.. (2020). Cost-effectiveness of balloon kyphoplasty and vertebroplasty versus conservative medical management in the USA. Osteoporosis International. 31(12). 2461–2471. 17 indexed citations
9.
Al-Senani, Fahmi, Mohammed Aljohani, Saeed Alzahrani, et al.. (2019). A national economic and clinical model for ischemic stroke care development in Saudi Arabia: A call for change. International Journal of Stroke. 14(8). 835–842. 19 indexed citations
10.
Al-Senani, Fahmi, et al.. (2019). An Epidemiological Model for First Stroke in Saudi Arabia. Journal of Stroke and Cerebrovascular Diseases. 29(1). 104465–104465. 45 indexed citations
11.
Holm, Allison Kaigle, et al.. (2018). PMD44 - COST COMPARISON OF RECHARGEABLE AND NON-RECHARGEABLE DEEP BRAIN STIMULATION DEVICES IN THE NORDIC COUNTRIES. Value in Health. 21. S249–S250. 1 indexed citations
14.
Eggington, Simon, et al.. (2015). Economic Value of Stemi Program Investment In Sao Paulo, Brazil. Value in Health. 18(7). A861–A861. 1 indexed citations
15.
Eggington, Simon, et al.. (2015). Cost-Effectiveness Of Deep Brain Stimulation (Dbs) In The Management Of Advanced Parkinson’s Disease: A Swedish Payer Perspective. Value in Health. 18(7). A352–A352. 4 indexed citations
17.
Reynolds, Matthew R., Mark Lamotte, Derick Todd, et al.. (2014). Cost-effectiveness of cryoballoon ablation for the management of paroxysmal atrial fibrillation. EP Europace. 16(5). 652–659. 30 indexed citations
19.
Eggington, Simon, Paul Tappenden, Abdullah Pandor, et al.. (2006). Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer. British Journal of Cancer. 95(9). 1195–1201. 27 indexed citations
20.
Tappenden, Paul, J. Chilcott, Sue Ward, et al.. (2006). Methodological issues in the economic analysis of cancer treatments. European Journal of Cancer. 42(17). 2867–2875. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026